Intelicare Holdings Limited
Intelicare Holdings Limited ICR.AX Peers
See (ICR.AX) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ICR.AX | A$0.01 | +0.00% | 2.9M | -0.60 | -A$0.01 | N/A |
| PME.AX | A$285.08 | +0.00% | 29.4B | 299.66 | A$0.94 | +0.17% |
| CGS.AX | A$1.75 | +0.29% | 295.4M | 25.00 | A$0.07 | N/A |
| VHT.AX | A$1.15 | +0.44% | 291.3M | -28.63 | -A$0.04 | N/A |
| ONE.AX | A$0.25 | +0.00% | 196.8M | -8.33 | -A$0.03 | N/A |
| ALC.AX | A$0.10 | +0.00% | 147.7M | -11.00 | -A$0.01 | N/A |
| SHG.AX | A$0.37 | +0.00% | 111.1M | -20.00 | -A$0.02 | N/A |
| M7T.AX | A$0.33 | +0.00% | 82M | -17.00 | -A$0.02 | N/A |
| AYA.AX | A$0.72 | +0.00% | 79M | -3.89 | -A$0.18 | N/A |
| PCK.AX | A$0.05 | +0.00% | 73.7M | -4.00 | -A$0.01 | N/A |
Stock Comparison
ICR.AX vs PME.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, PME.AX has a market cap of 29.4B. Regarding current trading prices, ICR.AX is priced at A$0.01, while PME.AX trades at A$285.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas PME.AX's P/E ratio is 299.66. In terms of profitability, ICR.AX's ROE is -10.86%, compared to PME.AX's ROE of +0.48%. Regarding short-term risk, ICR.AX is more volatile compared to PME.AX. This indicates potentially higher risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs CGS.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, CGS.AX has a market cap of 295.4M. Regarding current trading prices, ICR.AX is priced at A$0.01, while CGS.AX trades at A$1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas CGS.AX's P/E ratio is 25.00. In terms of profitability, ICR.AX's ROE is -10.86%, compared to CGS.AX's ROE of +0.20%. Regarding short-term risk, ICR.AX is more volatile compared to CGS.AX. This indicates potentially higher risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs VHT.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, VHT.AX has a market cap of 291.3M. Regarding current trading prices, ICR.AX is priced at A$0.01, while VHT.AX trades at A$1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas VHT.AX's P/E ratio is -28.63. In terms of profitability, ICR.AX's ROE is -10.86%, compared to VHT.AX's ROE of -0.18%. Regarding short-term risk, ICR.AX is more volatile compared to VHT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs ONE.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, ONE.AX has a market cap of 196.8M. Regarding current trading prices, ICR.AX is priced at A$0.01, while ONE.AX trades at A$0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas ONE.AX's P/E ratio is -8.33. In terms of profitability, ICR.AX's ROE is -10.86%, compared to ONE.AX's ROE of -1.17%. Regarding short-term risk, ICR.AX is more volatile compared to ONE.AX. This indicates potentially higher risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs ALC.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, ALC.AX has a market cap of 147.7M. Regarding current trading prices, ICR.AX is priced at A$0.01, while ALC.AX trades at A$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas ALC.AX's P/E ratio is -11.00. In terms of profitability, ICR.AX's ROE is -10.86%, compared to ALC.AX's ROE of -0.06%. Regarding short-term risk, ICR.AX is more volatile compared to ALC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs SHG.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, SHG.AX has a market cap of 111.1M. Regarding current trading prices, ICR.AX is priced at A$0.01, while SHG.AX trades at A$0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas SHG.AX's P/E ratio is -20.00. In terms of profitability, ICR.AX's ROE is -10.86%, compared to SHG.AX's ROE of -0.80%. Regarding short-term risk, ICR.AX is more volatile compared to SHG.AX. This indicates potentially higher risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs M7T.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, M7T.AX has a market cap of 82M. Regarding current trading prices, ICR.AX is priced at A$0.01, while M7T.AX trades at A$0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas M7T.AX's P/E ratio is -17.00. In terms of profitability, ICR.AX's ROE is -10.86%, compared to M7T.AX's ROE of -0.10%. Regarding short-term risk, ICR.AX is more volatile compared to M7T.AX. This indicates potentially higher risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs AYA.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, AYA.AX has a market cap of 79M. Regarding current trading prices, ICR.AX is priced at A$0.01, while AYA.AX trades at A$0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas AYA.AX's P/E ratio is -3.89. In terms of profitability, ICR.AX's ROE is -10.86%, compared to AYA.AX's ROE of -0.92%. Regarding short-term risk, ICR.AX is more volatile compared to AYA.AX. This indicates potentially higher risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs PCK.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, PCK.AX has a market cap of 73.7M. Regarding current trading prices, ICR.AX is priced at A$0.01, while PCK.AX trades at A$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas PCK.AX's P/E ratio is -4.00. In terms of profitability, ICR.AX's ROE is -10.86%, compared to PCK.AX's ROE of -4.53%. Regarding short-term risk, ICR.AX is less volatile compared to PCK.AX. This indicates potentially lower risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs BMT.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, BMT.AX has a market cap of 69.6M. Regarding current trading prices, ICR.AX is priced at A$0.01, while BMT.AX trades at A$0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas BMT.AX's P/E ratio is -12.00. In terms of profitability, ICR.AX's ROE is -10.86%, compared to BMT.AX's ROE of -0.12%. Regarding short-term risk, ICR.AX is more volatile compared to BMT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs MDR.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, MDR.AX has a market cap of 53.1M. Regarding current trading prices, ICR.AX is priced at A$0.01, while MDR.AX trades at A$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas MDR.AX's P/E ratio is -8.50. In terms of profitability, ICR.AX's ROE is -10.86%, compared to MDR.AX's ROE of -0.09%. Regarding short-term risk, ICR.AX is more volatile compared to MDR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs DOC.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, DOC.AX has a market cap of 42.2M. Regarding current trading prices, ICR.AX is priced at A$0.01, while DOC.AX trades at A$0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas DOC.AX's P/E ratio is -3.83. In terms of profitability, ICR.AX's ROE is -10.86%, compared to DOC.AX's ROE of -5.56%. Regarding short-term risk, ICR.AX is more volatile compared to DOC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs COO.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, COO.AX has a market cap of 26.3M. Regarding current trading prices, ICR.AX is priced at A$0.01, while COO.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas COO.AX's P/E ratio is N/A. In terms of profitability, ICR.AX's ROE is -10.86%, compared to COO.AX's ROE of -0.05%. Regarding short-term risk, ICR.AX is more volatile compared to COO.AX. This indicates potentially higher risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs RHT.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, RHT.AX has a market cap of 18.8M. Regarding current trading prices, ICR.AX is priced at A$0.01, while RHT.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas RHT.AX's P/E ratio is N/A. In terms of profitability, ICR.AX's ROE is -10.86%, compared to RHT.AX's ROE of -0.03%. Regarding short-term risk, ICR.AX is more volatile compared to RHT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs 1ST.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, 1ST.AX has a market cap of 15.6M. Regarding current trading prices, ICR.AX is priced at A$0.01, while 1ST.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas 1ST.AX's P/E ratio is -1.10. In terms of profitability, ICR.AX's ROE is -10.86%, compared to 1ST.AX's ROE of +0.69%. Regarding short-term risk, ICR.AX is more volatile compared to 1ST.AX. This indicates potentially higher risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs IME.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, IME.AX has a market cap of 15.6M. Regarding current trading prices, ICR.AX is priced at A$0.01, while IME.AX trades at A$0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas IME.AX's P/E ratio is -4.83. In terms of profitability, ICR.AX's ROE is -10.86%, compared to IME.AX's ROE of -0.18%. Regarding short-term risk, ICR.AX is more volatile compared to IME.AX. This indicates potentially higher risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs EMD.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, EMD.AX has a market cap of 13.3M. Regarding current trading prices, ICR.AX is priced at A$0.01, while EMD.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas EMD.AX's P/E ratio is -0.90. In terms of profitability, ICR.AX's ROE is -10.86%, compared to EMD.AX's ROE of -0.56%. Regarding short-term risk, ICR.AX is more volatile compared to EMD.AX. This indicates potentially higher risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs OPL.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, OPL.AX has a market cap of 6.6M. Regarding current trading prices, ICR.AX is priced at A$0.01, while OPL.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas OPL.AX's P/E ratio is -2.80. In terms of profitability, ICR.AX's ROE is -10.86%, compared to OPL.AX's ROE of +12.65%. Regarding short-term risk, ICR.AX is more volatile compared to OPL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs HIQ.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, HIQ.AX has a market cap of 6.1M. Regarding current trading prices, ICR.AX is priced at A$0.01, while HIQ.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas HIQ.AX's P/E ratio is -1.50. In terms of profitability, ICR.AX's ROE is -10.86%, compared to HIQ.AX's ROE of +2.49%. Regarding short-term risk, ICR.AX is more volatile compared to HIQ.AX. This indicates potentially higher risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs MEB.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, MEB.AX has a market cap of 4.5M. Regarding current trading prices, ICR.AX is priced at A$0.01, while MEB.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas MEB.AX's P/E ratio is -0.10. In terms of profitability, ICR.AX's ROE is -10.86%, compared to MEB.AX's ROE of -0.47%. Regarding short-term risk, ICR.AX is less volatile compared to MEB.AX. This indicates potentially lower risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs TD1.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, TD1.AX has a market cap of 4.1M. Regarding current trading prices, ICR.AX is priced at A$0.01, while TD1.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas TD1.AX's P/E ratio is -0.10. In terms of profitability, ICR.AX's ROE is -10.86%, compared to TD1.AX's ROE of -0.24%. Regarding short-term risk, ICR.AX is less volatile compared to TD1.AX. This indicates potentially lower risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs GLH.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, GLH.AX has a market cap of 3.9M. Regarding current trading prices, ICR.AX is priced at A$0.01, while GLH.AX trades at A$0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas GLH.AX's P/E ratio is -6.70. In terms of profitability, ICR.AX's ROE is -10.86%, compared to GLH.AX's ROE of +0.27%. Regarding short-term risk, ICR.AX is less volatile compared to GLH.AX. This indicates potentially lower risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs CTQ.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, CTQ.AX has a market cap of 2.6M. Regarding current trading prices, ICR.AX is priced at A$0.01, while CTQ.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas CTQ.AX's P/E ratio is -1.10. In terms of profitability, ICR.AX's ROE is -10.86%, compared to CTQ.AX's ROE of -0.62%. Regarding short-term risk, ICR.AX is more volatile compared to CTQ.AX. This indicates potentially higher risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs OAK.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, OAK.AX has a market cap of 1.7M. Regarding current trading prices, ICR.AX is priced at A$0.01, while OAK.AX trades at A$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas OAK.AX's P/E ratio is -1.60. In terms of profitability, ICR.AX's ROE is -10.86%, compared to OAK.AX's ROE of -0.44%. Regarding short-term risk, ICR.AX is more volatile compared to OAK.AX. This indicates potentially higher risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs JTL.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, JTL.AX has a market cap of 281.3K. Regarding current trading prices, ICR.AX is priced at A$0.01, while JTL.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas JTL.AX's P/E ratio is -0.10. In terms of profitability, ICR.AX's ROE is -10.86%, compared to JTL.AX's ROE of +0.60%. Regarding short-term risk, ICR.AX is more volatile compared to JTL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for ICR.AX.
ICR.AX vs TTB.AX Comparison
ICR.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICR.AX stands at 2.9M. In comparison, TTB.AX has a market cap of 267.4K. Regarding current trading prices, ICR.AX is priced at A$0.01, while TTB.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICR.AX currently has a P/E ratio of -0.60, whereas TTB.AX's P/E ratio is -0.02. In terms of profitability, ICR.AX's ROE is -10.86%, compared to TTB.AX's ROE of -1.05%. Regarding short-term risk, ICR.AX is more volatile compared to TTB.AX. This indicates potentially higher risk in terms of short-term price fluctuations for ICR.AX.